Delivery Order 36F79723D0188-70B03C24F00000279
- This is a federal contract award to Emergent Devices, Inc., a for-profit organization and manufacturer of goods, to provide NARCAN (naloxone nasal spray) to the Department of Homeland Security Customs and Border Protection. The contract is a Delivery Order valued at $288,456.00 and is issued under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, which Emergent Devices holds through August 2028. The contract is not set aside. NARCAN is an overdose reversal medication that...
- The Department of Homeland Security's Customs and Border Protection awarded Emergent Devices, Inc., a for-profit manufacturer, a $152,712 firm-fixed-price delivery order contract for NARCAN, a naloxone nasal spray used to rapidly reverse opioid overdoses. This order was placed against Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceutical and hematology products, which runs through August 2028. Emergent Devices has previously provided NARCAN to other federal agencies,...
- This is a delivery order contract awarded to Emergent Devices, Inc. by the U.S. Customs and Border Protection (CBP) agency, a civilian federal agency. The contract is for the supply of NALOXONE/NARCAN NASAL SPRAY, which is used to rapidly reverse opioid overdoses. The contract has a ceiling value of $150,465.60 and a completion date of August 25, 2019. Emergent Devices, Inc. is a for-profit pharmaceutical manufacturer that specializes in providing medical countermeasures to the U.S. federal...
- This is a delivery order contract awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to purchase NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The contract has a firm fixed price of $15,921.60 and a completion date of May 31, 2024. Emergent Devices holds multiple federal contracts and grant sub-awards to supply naloxone products, including NARCAN, to various government...
- This is a delivery order awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the purchase of NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The award is for a Firm Fixed Price contract with a ceiling value of $18,995.76 and a completion date of June 1, 2024. Emergent Devices is a subsidiary of Emergent BioSolutions and is a key supplier of naloxone products to various...
- This federal contract award is for the delivery of NOSE SPRAY to the U.S. Customs and Border Protection (CBP), a civilian agency. The $148,262.40 firm fixed-price delivery order was awarded on August 27, 2018 to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer that specializes in providing medical countermeasures to the U.S. government, with a focus on naloxone products used to reverse opioid overdoses. Emergent Devices holds multiple federal contracts and grant sub-awards to...
- This federal contract award is for the delivery of NARCAN NASAL SPRAY to the Immigration and Customs Enforcement agency. The contract was awarded to Emergent Devices, Inc., a for-profit organization and manufacturer of pharmaceuticals and medical devices. The contract has a firm fixed price of $205,312.80 and was awarded on June 4, 2020, with a completion date of July 4, 2020. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the...
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $452,280.00 and a performance period ending on February 2, 2017. This contract is not set-aside and is awarded under Emergent Devices' existing $11.8 million multiple-award Federal Supply Schedule...
- This federal contract award to Emergent Devices, Inc. is for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract was awarded by the U.S. Department of Veterans Affairs, with a ceiling value of $455,898.24. Emergent Devices is a for-profit pharmaceutical manufacturer that specializes in supplying medical countermeasures to the federal government, including various naloxone formulations to address the ongoing opioid crisis. This contract...
- The U.S. Immigration and Customs Enforcement (ICE) awarded a Firm Fixed Price Delivery Order to Emergent Devices, Inc., a manufacturer of pharmaceutical products, for the provision of NARCAN (naloxone nasal spray) with a potential value of $101,310.72. The order was placed under Emergent Devices' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). NARCAN is an emergency medication used to rapidly reverse opioid overdoses. Emergent Devices has previously received...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79723D0188Federal Supply Schedule
- 36F79723D0188-70B03C24F00000279Delivery Order
This federal contract award is for Emergent Devices, Inc. to procure 4,320 two-dose cycles (8,640 courses) of NARCAN (naloxone HCI) nasal spray 4mg applicator/cartridges for the U.S. Customs and Border Protection agency. The contract has a ceiling value of $162,820.80 and a completion date of September 30, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Emergent Devices, a for-profit pharmaceutical manufacturer, is the prime contractor on this award. The company holds multiple federal contracts and grant sub-awards to supply NARCAN and other naloxone products to various government agencies, including the Department of Veterans Affairs, Department of Homeland Security, and Department of Justice, in support of public health and safety initiatives addressing the opioid crisis. Emergent Devices has two significant federal contract indefinite delivery vehicles with the Department of Veterans Affairs and the Department of the Navy Criminal Investigative Service for naloxone products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $162.8k | 5/7/24 |